These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23444008)

  • 1. Advanced imaging improves prediction of hemorrhage after stroke thrombolysis.
    Campbell BC; Christensen S; Parsons MW; Churilov L; Desmond PM; Barber PA; Butcher KS; Levi CR; De Silva DA; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM;
    Ann Neurol; 2013 Apr; 73(4):510-9. PubMed ID: 23444008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reperfusion of very low cerebral blood volume lesion predicts parenchymal hematoma after endovascular therapy.
    Mishra NK; Christensen S; Wouters A; Campbell BC; Straka M; Mlynash M; Kemp S; Cereda CW; Bammer R; Marks MP; Albers GW; Lansberg MG;
    Stroke; 2015 May; 46(5):1245-9. PubMed ID: 25828235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke.
    Campbell BC; Christensen S; Butcher KS; Gordon I; Parsons MW; Desmond PM; Barber PA; Levi CR; Bladin CF; De Silva DA; Donnan GA; Davis SM;
    Stroke; 2010 Jan; 41(1):82-8. PubMed ID: 19959537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation.
    Campbell BC; Costello C; Christensen S; Ebinger M; Parsons MW; Desmond PM; Barber PA; Butcher KS; Levi CR; De Silva DA; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM;
    Cerebrovasc Dis; 2011; 32(4):401-5. PubMed ID: 21986096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated glucose is associated with hemorrhagic transformation after mechanical thrombectomy in acute ischemic stroke patients with severe pretreatment hypoperfusion.
    Laredo C; Renú A; Llull L; Tudela R; López-Rueda A; Urra X; Macías NG; Rudilosso S; Obach V; Amaro S; Chamorro Á
    Sci Rep; 2020 Jun; 10(1):10588. PubMed ID: 32601437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of poststroke hemorrhagic transformation using computed tomography perfusion.
    Yassi N; Parsons MW; Christensen S; Sharma G; Bivard A; Donnan GA; Levi CR; Desmond PM; Davis SM; Campbell BC
    Stroke; 2013 Nov; 44(11):3039-43. PubMed ID: 24003043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemic Core and Hypoperfusion Volumes Correlate With Infarct Size 24 Hours After Randomization in DEFUSE 3.
    Rao V; Christensen S; Yennu A; Mlynash M; Zaharchuk G; Heit J; Marks MP; Lansberg MG; Albers GW
    Stroke; 2019 Mar; 50(3):626-631. PubMed ID: 30727840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke.
    Alsop DC; Makovetskaya E; Kumar S; Selim M; Schlaug G
    Stroke; 2005 Apr; 36(4):746-50. PubMed ID: 15746457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
    Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
    Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of alteplase 3 to 6 hours after stroke in the EPITHET-DEFUSE combined dataset: post hoc case-control study.
    Ogata T; Christensen S; Nagakane Y; Ma H; Campbell BC; Churilov L; Lansberg MG; Straka M; De Silva DA; Mlynash M; Bammer R; Olivot JM; Desmond PM; Albers GW; Davis SM; Donnan GA;
    Stroke; 2013 Jan; 44(1):87-93. PubMed ID: 23250996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set.
    Mlynash M; Lansberg MG; De Silva DA; Lee J; Christensen S; Straka M; Campbell BC; Bammer R; Olivot JM; Desmond P; Donnan GA; Davis SM; Albers GW;
    Stroke; 2011 May; 42(5):1270-5. PubMed ID: 21474799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater effect of stroke thrombolysis in the presence of arterial obstruction.
    De Silva DA; Churilov L; Olivot JM; Christensen S; Lansberg MG; Mlynash M; Campbell BC; Desmond P; Straka M; Bammer R; Albers GW; Davis SM; Donnan GA;
    Ann Neurol; 2011 Oct; 70(4):601-5. PubMed ID: 22028220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very low cerebral blood volume predicts parenchymal hematoma in acute ischemic stroke.
    Hermitte L; Cho TH; Ozenne B; Nighoghossian N; Mikkelsen IK; Ribe L; Baron JC; Østergaard L; Derex L; Hjort N; Fiehler J; Pedraza S; Hermier M; Maucort-Boulch D; Berthezène Y
    Stroke; 2013 Aug; 44(8):2318-20. PubMed ID: 23723309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extension of therapeutic window in ischemic stroke by selective mismatch imaging.
    Heiss WD; Zaro-Weber O
    Int J Stroke; 2019 Jun; 14(4):351-358. PubMed ID: 30935350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke.
    Lansberg MG; Thijs VN; Bammer R; Kemp S; Wijman CA; Marks MP; Albers GW;
    Stroke; 2007 Aug; 38(8):2275-8. PubMed ID: 17569874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke.
    Puig J; Blasco G; Daunis-I-Estadella P; van Eendendburg C; Carrillo-García M; Aboud C; Hernández-Pérez M; Serena J; Biarnés C; Nael K; Liebeskind DS; Thomalla G; Menon BK; Demchuk A; Wintermark M; Pedraza S; Castellanos M
    PLoS One; 2017; 12(11):e0188238. PubMed ID: 29182658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.